NYSE
CI
Last Price
US $275.68
KEY FIGURES
MKT CAP
$74.8B
EPS
TTM
$23.95
PEG
TTM
0.39x
P/E
TTM
11.92x
P/S
TTM
0.27x
YIELD
2.17%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Cigna Corporation cash flow to debt ratio of 30.52% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Cigna Corporation's free cash flow has decreased -6.34% from $8.96G last year to $8.39G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Cigna Corporation's debt to equity ratio is 0.73, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Cigna Corporation's debt has decreased relative to shareholder equity from 0.78 last year to 0.73 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Cigna Corporation has a net debt to EBITDA ratio of 2.05x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Cigna Corporation's interest coverage ratio of 6.92 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Cigna Corporation's profit margin has increased (62.80%) in the last year from 1.39% to 2.26%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Cigna Corporation's short-term liabilities of $56.34G exceed its short-term assets of $47.81G, signaling financial risk
Decreasing performance - ROA.
Cigna Corporation's return on assets of 4.10% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
Cigna Corporation's return on equity of 15.16%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Cigna Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Cigna Corporation had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Cigna Corporation has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Cigna Corporation has a free cash flow yield of 11.21%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Cigna Corporation's yearly earnings has increased 73.47% since last year from $3.43G to $5.96G, signaling increasing performance
Increasing performance - Healthy revenue growth.
Cigna Corporation's yearly revenue has increased 11.26% since last year from $247.12G to $274.95G, signaling increasing performance
Increasing performance - ROIC.
ROIC 7.59% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Cigna Corporation's 3-year revenue CAGR of 15.06% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Cigna Corporation had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Cigna Corporation had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Cigna Corporation is overvalued relative to its fair value price of 248.98 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Cigna Corporation has an earnings yield of 8.47%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Cigna Corporation is overvalued relative to its fair value price of 215.12 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Cigna Corporation has an EV/EBITDA ratio of 8.09x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Cigna Corporation has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Cigna Corporation has a price-to-book ratio of 1.76x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Cigna Corporation has a price-to-sales ratio of 0.27x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
15.16%
Return on equity
ROIC: 7.59%
Valuation History
11.9X
Price to Earnings
EV/EBITDA: 8.1X
Cash flow
Profit margin
11.38%
(FY vs FY)
EBITDA Y/Y
2.28%
(FY vs FY)
Cash flow Y/Y
-1.95%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $275.68
-9.69%
Default assumptions
EBITDA Multiple
Fair Value
Market $275.68
-21.97%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.